We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Optibiotix Health Plc | LSE:OPTI | London | Ordinary Share | GB00BP0RTP38 | ORD 2P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-1.25 | -7.46% | 15.50 | 15.00 | 16.00 | 16.75 | 15.50 | 16.75 | 595,508 | 10:34:59 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Noncomml Resh Organizations | 644k | -2.04M | -0.0208 | -7.45 | 16.41M |
Date | Subject | Author | Discuss |
---|---|---|---|
06/6/2018 08:28 | I hope "Seed" get their launch right as they seem very high profile. Hope all their products (ingredients) are as good as OPTI's. | m4rtinu | |
06/6/2018 08:11 | Vital, all the human safety studies have been done including LPLDL it will be hard for them to leave it out now | trotterstrading | |
06/6/2018 08:06 | Seed.com appears to be a very well presented product.As only the yanks can do?Just wondering how important the OPTI contribution is in the total product. Maybe essential, hopefully so. | aspex | |
06/6/2018 08:02 | Well OPTI's strain is definitely in the new Seed product Listed under the "Whats Inside" section. Seed Cardiovascular Health Probiotic Blend Lactobacillus plantarum SD-LDL1-UK - THIS IS OPTI HERE Bifidiobacterium lactis SD-MB2409-IT Bifidobacterium longum SD-BL4-IT | woodaldo | |
06/6/2018 07:47 | Investors are much more likely to buy in if they can see actual products on the shelves and Seed is the most high profile launch so far. | parob | |
06/6/2018 07:36 | Agree FredD and perfect for the market they're targeting. | parob | |
06/6/2018 07:34 | You never know, we may get an RNS later today to tie in with the launch of marketing Stateside; after all, it's half past two in the morning there. Perhaps I'm clutching at straws but, as stated, it would be a good way of drawing attention to the product launch - possibly tomorrow if not. | colinzeal | |
06/6/2018 07:32 | I find the Seed.com website very impressive. | fredd | |
06/6/2018 07:14 | $49.99 per month ($59.99 retail) for both the female and male supplement. | parob | |
06/6/2018 07:08 | Seed.com website live with products on shelves. $$$ | colinzeal | |
05/6/2018 21:35 | Golden cross is about two weeks away. | parob | |
05/6/2018 19:13 | Pj - pretty jammy Can you make number 3 a prediction of uk partner named as boots the chemist! | shrewdmole | |
05/6/2018 19:13 | To be honest Shrewd it's a no brainer. All the fundamentals are in place. I am not into euphemisms however not seen a company so primed for share price acceleration since probably Knutsford Holdings. Takes me back...... | parsnip1 | |
05/6/2018 19:12 | To be honest Shrewd it's a no brainer. All the fundamentals are in place. I am not into euphemisms however not seen a company so primed for share price acceleration since probably Knutsford Holdings. Takes me back...... | parsnip1 | |
05/6/2018 19:05 | lol That's 2 in a row I've called correct so 1 more, assuming things come in 3's, before status quo kicks back in!! | pj 1 | |
05/6/2018 19:03 | Parsnip It's so tempting isn't it..... S | shrewdmole | |
05/6/2018 18:59 | The 50k was a buy. I confess. Odd showing as a sell | parsnip1 | |
05/6/2018 18:55 | A repost of my post made just after last week's placing RNS:I get the impression we won't be waiting too long until a Pharma partner in the USA is announced. Skin deal with UOM came the following month after the Feb 2016 placing. SOH comment in RNS at the time:"The funds will be used to further accelerate our development programmes to capitalise on the growing number of opportunities arising in the rapidly evolving microbiome space and build shareholder value."Look where SBTX is now.SOH comment after recent placement: "It has become clear that new opportunities, particularly the development of LP(LDL) (R) into a pharmaceutical product, the high level of corporate interest in SweetBiotix across multiple applications, and the potential for listing a range of Health and Wellbeing products with major retailers are not achievable in the short term within current resources. Rather than delay these opportunities until OptiBiotix has sufficient revenues to cover costs, the Board has decided to take additional funds to capitalise on these growth opportunities and build shareholder value."I think we have a good idea of what's coming next. | parob | |
05/6/2018 18:36 | I cant help thinking by the price action that 50k @ 70p was a limit order. (or part of a limit order) We will never know off course unless anyone confesses! | pj 1 | |
05/6/2018 18:05 | Nobby They were bidding strong even when the price was down. Someone's in for more I think as they've been bidding very well in large size. S | shrewdmole | |
05/6/2018 17:57 | Very encouraging end to the day. It seems that very few of the placees are selling any stock. I am sure the MMs were banking on that to fill their short books so IMHO we could see a sharp rise now. Nobby | nobbygnome | |
05/6/2018 16:44 | Market launch for LPLDL® capsules in GermanyThis RNS was not RNS Reach. hTtp://www.londonsto | parob | |
05/6/2018 16:39 | that was a very strong movement this pm. premium being paid at close for smallish amounts. going to get very interesting very soon. | shrewdmole | |
05/6/2018 16:35 | To draw attention to the product launch and create interest in the market...could be released as an RNS Reach. | colinzeal |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions